By Eddie Staley
Square 1 Bank, the premier banking partner to entrepreneurs and the venture capital community, announced today that it has provided a $10 million credit facility to new client TissueTech™, Inc., a regenerative tissue-engineering company that provides therapeutic technologies to the ophthalmology, optometry, orthopedic and wound care markets. Proceeds of the credit facility will provide working capital for the Company’s sales force expansion and pursuit of additional growth opportunities.
TissueTech™ offers its portfolio of amniotic membrane and umbilical cord-based tissue and device products through its commercial subsidiaries: Bio-Tissue® Inc., the industry leader in regenerative biologic therapies and ocular hygiene solutions for the treatment of ocular surface diseases and disorders, and Amniox® Medical Inc., a leading provider of regenerative tissue therapies to the musculoskeletal and wound care markets.
